Renaissance Technologies (RenTech)'s RLAY Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 673,599 shares of Relay Therapeutics, Inc. (RLAY) worth $6.7 M, representing 0.01% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in RLAY, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 878,095 shares. Largest reduction occurred in Q2 2025, reducing 767,900 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Relay Therapeutics (RLAY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Relay Therapeutics (RLAY) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +25,700 | Add 3.97% | 673,599 | $9.95 |
| Q4 2025 | -375,211 | Reduce 36.67% | 647,899 | $8.46 |
| Q3 2025 | -485,100 | Reduce 32.16% | 1.02 M | $5.22 |
| Q2 2025 | -767,900 | Reduce 33.74% | 1.51 M | $3.46 |
| Q1 2025 | +726,920 | Add 46.92% | 2.28 M | $2.62 |
| Q4 2024 | +878,095 | Add 130.85% | 1.55 M | $4.12 |
| Q3 2024 | -237,942 | Reduce 26.18% | 671,095 | $7.08 |
| Q2 2024 | +145,837 | Add 19.11% | 909,037 | $6.52 |
| Q1 2024 | +439,500 | Add 135.77% | 763,200 | $8.30 |
| Q4 2023 | +179,000 | Add 123.70% | 323,700 | $11.01 |
| Q3 2023 | +144,700 | New Buy | 144,700 | $8.41 |
| Q2 2023 | -118,854 | Sold Out | 0 | $0.00 |
| Q1 2023 | +58,054 | Add 95.48% | 118,854 | $0.02 |
| Q4 2022 | +60,800 | New Buy | 60,800 | $0.01 |
| Q3 2022 | -25,900 | Sold Out | 0 | $0.00 |
| Q2 2022 | -1,900 | Reduce 6.83% | 25,900 | $16.76 |
| Q1 2022 | +20,800 | Add 297.14% | 27,800 | $29.93 |
| Q4 2021 | -145,588 | Reduce 95.41% | 7,000 | $30.71 |
| Q3 2021 | +152,588 | New Buy | 152,588 | $31.53 |
Renaissance Technologies (RenTech)'s Relay Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Relay Therapeutics, Inc. (RLAY) in Q3 2021, acquiring 152,588 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Relay Therapeutics, Inc. (RLAY) for 19 quarters since Q3 2021.
Renaissance Technologies (RenTech)'s largest addition to Relay Therapeutics, Inc. (RLAY) was in Q4 2024, adding 1,549,190 shares worth $6.38 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 673,599 shares of Relay Therapeutics, Inc. (RLAY), valued at approximately $6.7 M.
As of the Q1 2026 filing, Relay Therapeutics, Inc. (RLAY) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Relay Therapeutics, Inc. (RLAY) was 2,276,110 shares, as reported at the end of Q1 2025.